Funds to support innovation and answers in WA state research institutions Sept. 21, 2023 For Immediate Release Molly O’Connor, CEO(206) 490-0878; molly.oconnor@rivkin.org SEATTLE – Washington state ovarian cancer researchers will have an extra $1M in grant funding over the next two years thanks to a pioneering public-private partnership between the Rivkin Center for Ovarian Cancer […]
Read More
To say that a cure for ovarian cancer, or any cancer for that matter, is the “holy grail” of cancer research is like saying the sky is blue. We all know a cure is the goal. If a cure is the goal, then improved detection, new prevention methods, and new treatments are the low-hanging fruit. […]
Read More
The serious Covid-19 pandemic has raised our concern about personal safety and health. Early on, we got solid advice about physical distancing, hand washing, and wearing masks. Then the vaccine arrived. Wisely, many have been vaccinated, even boosted. Great! Still, we’ve been cautioned about other activities from gathering with small groups and dining in public […]
Read More
Learn the signs and symptoms of breast and ovarian cancer so you can be proactive about your health.
Read More
At high risk for breast or ovarian cancer? Here’s what you need to know about screening and prevention.
Read More
The Rivkin Center is proud to announce that we have awarded $810,000 in ovarian cancer research grants to nine scientists across the globe.
Read More
Dear Friends of the Rivkin Center: “Women’s Lives. Our Passion”. This underscores the core meaning of what the Rivkin Center does and why Dr. Saul Rivkin started this organization over 20 years ago to help women with ovarian cancer. Today our mission includes funding the best ovarian cancer research in the world and educating women […]
Read More
By Dan Veljovich, MD Dr. Dan Veljovich is a Gynecological Oncologist with Swedish Cancer Institute. Dr. Veljovich is also a member of the Rivkin Center Board of Directors. Questions were submitted by members of the Rivkin Center patient and survivor community. The ongoing COVID-19 pandemic has created a lot of worry and questions from our […]
Read More
We’re excited to share results of three recent studies that provide hope for women with newly diagnosed ovarian cancer. The studies, reported at the annual meeting of the European Society of Medical Oncology and two of which were published in the New England Journal of Medicine recently, show that three different types of PARP inhibitors […]
Read More
My mother-in-law, Marcia, was first diagnosed with breast cancer at the age of 38. Her older sister had been treated for breast cancer a few years before, so Marcia knew what to expect. Medicine had not yet linked genetics to cancer risk. Years later, science discovered the BRCA gene mutation and its link to breast […]
Read More